Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Procaps Group is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Brazil
Founded:2017
Employees:2,009
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval SYSYY7
PMDA · #APR-5QX3Q431 · 2022-12-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-NN9EIMM6
Issued: 2020-12-12
Expires: 2025-01-16
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-OTT0OUE3
Issued: 2020-11-01
Expires: 2025-10-01
Loading CDMO intelligence...
Key facts about Procaps Group
- Procaps Group is headquartered in Brazil.
- Procaps Group was founded in 2017.
- Procaps Group has 2,009 employees.
- Procaps Group's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Procaps Group
Directory pages this company appears in, each with the full list of matching manufacturers.